Feng Liu

Feng Liu currently serves as the Head of Biometrics at Immunocore, a position held since April 2024. Prior to this role, Feng Liu held the same title at Marengo Therapeutics, focusing on the development of the biometrics function to support a growing clinical portfolio from January 2023 to April 2024. Experience includes serving as Senior Director at Fate Therapeutics Inc from January 2021 to January 2023, leading statistical activities for cell therapies, and as Senior Director of Biostatistics at Intercept Pharmaceuticals in 2021, managing statistical efforts in clinical studies. Additional experience includes serving as Statistical Science Director for Oncology Biometrics at AstraZeneca from January 2018 to January 2021, providing expertise in late oncology clinical development and regulatory submissions. Feng Liu holds a PhD in Statistics from The University of Sheffield and a Master’s Degree in Statistics from Iowa State University.